Despite concerns about ADHD stimulant therapy as a gateway for future drug abuse, a new study shows that teens treated with stimulants later and for shorter durations, and those treated with non-stimulant medications, have higher rates of later drug abuse than their peers who have used stimulant therapy longer.
The amount of off-label uses of atypical antipsychotic drugs (AAPs) prescribed for children with attention-deficit/hyperactivity disorder (ADHD) raises questions about the appropriateness of AAPs for this indication.
For Contemporary Pediatrics, Dr Bobby Lazzara explains key findings from a study published in the Journal of Attention Disorders. The study looked at whether there was a correlation between ADHD and frustration tolerance in children.
Children with ADHD are more likely than their peers to consume less water, exercise less, and spend more time staring at screens—all behaviors that may be negatively affecting their ADHD symptoms, according to a new report.
Two recent studies fail to demonstrate conclusively whether the testing effect can benefit students with ADHD, but both acknowledge the need for more research about teaching strategies for learners with ADHD.
Fewer than half of children with attention-deficit/hyperactivity disorder (ADHD) were receiving behavior therapy just before the American Academy of Pediatrics released clinical practice guidelines in 2011, according to the first national study of behavior therapy, medication, and dietary supplements to treat ADHD in children aged 4 to 17 years.
A 17-year-old-male presented to a specialty clinic for follow-up of attention-deficit/hyperactivity disorder (ADHD), migraine headaches, adjustment disorder with mixed disturbance of emotion and conduct, and mood disorder. At this visit, he reported excessive daytime sleepiness that was interfering with academic tasks and “life.”